Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HBV-MPL vs Engerix-B in Hep B Vaccine Non-responders
NCT00698061Phase 3Completed
- Sponsor
- GSK
- Start
- Nov 1999
- Primary completion
- Sep 2000
- Modality
- Vaccines & Immunotherapeutics
01
Overview
A Phase 3 trial of hepatitis b vaccine recombinant in hepatitis B (HBV), sponsored by GSK. Started Nov 1999; status: completed.
02
Drugs
hepatitis b vaccine recombinant
03
Conditions
hepatitis B (HBV)
Beyond the preview
Go deeper on NCT00698061.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00698061.